.jpg?impolicy=m&im=Resize,width=3840)
10 September 2026 • 1 minute read
DLA Piper advises Typewriter Therapeutics in its Series A financing to advance genetic medicines
DLA Piper advised Typewriter Therapeutics, Inc., a biotechnology company focused on genetic medicines, in its US$56.3 million Series A financing. The transaction will support the company’s development of safe, durable, and re-dosable genetic medicines with curative impact for patients with cancer, autoimmune diseases, and severe genetic diseases.
The DLA Piper deal team was led by Partner Josh Seidenfeld (Palo Alto), who co-leads the firm’s Emerging Growth and Venture Capital practice and leads the firm’s Northern California Corporate and Securities practice, and included Associates Rachel Robichaux (Palo Alto) and Nava Majlesi (San Francisco).
DLA Piper’s Emerging Growth and Venture Capital practice includes more than 200 lawyers who provide strategic counsel to emerging companies and venture capital firms in high-growth industries, including technology, healthcare, life sciences, and financial services. Over the last three years, DLA Piper has completed more than 2,100 financings globally, totaling more than US$80 billion. The firm is ranked among the most active global law firms for venture capital deal volume, according to PitchBook.
The DLA Piper deal team was led by Partner Josh Seidenfeld (Palo Alto), who co-leads the firm’s Emerging Growth and Venture Capital practice and leads the firm’s Northern California Corporate and Securities practice, and included Associates Rachel Robichaux (Palo Alto) and Nava Majlesi (San Francisco).
DLA Piper’s Emerging Growth and Venture Capital practice includes more than 200 lawyers who provide strategic counsel to emerging companies and venture capital firms in high-growth industries, including technology, healthcare, life sciences, and financial services. Over the last three years, DLA Piper has completed more than 2,100 financings globally, totaling more than US$80 billion. The firm is ranked among the most active global law firms for venture capital deal volume, according to PitchBook.